Today Reps. Waxman, Dingell, and Brown sent a letter to Secretary Leavitt objecting to FDA’s claim that state lawsuits related to prescription drugs should be barred by FDA regulation of prescription drugs and pointing out that FDA justifies this claim with misleading statements and critical omissions. Sens. Kennedy and Dodd also also sent a letter to Secretary of Health and Human Services Leavitt urging him to withdraw language in a Food and Drug Administration drug labeling regulation that says FDA regulation of prescription drugs bars lawsuits against drug manufacturers and doctors, and questioning the justification for barring such lawsuits.